BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9354674)

  • 1. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).
    Falini B; Flenghi L; Fagioli M; Lo Coco F; Cordone I; Diverio D; Pasqualucci L; Biondi A; Riganelli D; Orleth A; Liso A; Martelli MF; Pelicci PG; Pileri S
    Blood; 1997 Nov; 90(10):4046-53. PubMed ID: 9354674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3.
    Villamor N; Costa D; Aymerich M; Esteve J; Carrió A; Rozman M; Aguilar JL; Falini B; Montserrat E; Campo E; Colomer D
    Am J Clin Pathol; 2000 Nov; 114(5):786-92. PubMed ID: 11068554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
    Grimwade D; Gorman P; Duprez E; Howe K; Langabeer S; Oliver F; Walker H; Culligan D; Waters J; Pomfret M; Goldstone A; Burnett A; Freemont P; Sheer D; Solomon E
    Blood; 1997 Dec; 90(12):4876-85. PubMed ID: 9389704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
    Gomis F; Sanz J; Sempere A; Plumé G; Senent ML; Pérez ML; Cervera J; Moscardó F; Bolufer P; Barragán E; Martín G; Sanz MA
    Ann Hematol; 2004 Nov; 83(11):687-90. PubMed ID: 15278297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia.
    Flenghi L; Fagioli M; Tomassoni L; Pileri S; Gambacorta M; Pacini R; Grignani F; Casini T; Ferrucci PF; Martelli MF
    Blood; 1995 Apr; 85(7):1871-80. PubMed ID: 7535592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-alpha protein.
    Dyck JA; Warrell RP; Evans RM; Miller WH
    Blood; 1995 Aug; 86(3):862-7. PubMed ID: 7620182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
    Biondi A; Luciano A; Bassan R; Mininni D; Specchia G; Lanzi E; Castagna S; Cantù-Rajnoldi A; Liso V; Masera G
    Leukemia; 1995 Sep; 9(9):1461-6. PubMed ID: 7658712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia.
    Schoch C; Schnittger S; Kern W; Lengfelder E; Löffler H; Hiddemann W; Haferlach T
    Hematol J; 2002; 3(5):259-63. PubMed ID: 12391544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: a comparative study of RT-PCR cytogenetics, and fluorescence In situ hybridization.
    Rennert H; Golde T; Wilson RB; Spitalnik SL; Van Deerlin VM; Leonard DG
    Mol Diagn; 1999 Sep; 4(3):195-209. PubMed ID: 10553020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new cryptic PML-RARα fusion gene without t(15;17) and biallelic CEBPA mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISH.
    Zhang Z; Xu Y; Jiang M; Kong F; Chen Z; Liu S; Li F
    Cancer Biol Ther; 2020 Apr; 21(4):309-314. PubMed ID: 31959056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
    Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and monitoring of PML-RARalpha-positive acute promyelocytic leukemia by quantitative RT-PCR.
    Mokany E; Todd AV; Fuery CJ; Applegate TL
    Methods Mol Med; 2006; 125():127-47. PubMed ID: 16502582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improved RT-PCR for detection of PML/RARalpha fusion gene in rapid diagnosis of acute promyelocytic leukemia].
    Liu ZL; Luo JM; Wang FX; Zhang XJ; Du XY; Yao L; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):587-90. PubMed ID: 14706140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.
    Sucić M; Zadro R; Burazer B; Labar B; Nemet D; Mrsić M; Aurer I; Mrsić S; Hitrec V; Boban D; Marković-Glamocak M; Batinić D; Uzarević B; Stavljenić-Rukavina A
    J Hematother Stem Cell Res; 2002 Dec; 11(6):941-50. PubMed ID: 12590709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic.
    Andre C; Guillemin MC; Zhu J; Koken MH; Quignon F; Herve L; Chelbi-Alix MK; Dhumeaux D; Wang ZY; Degos L; Chen Z; de The H
    Exp Cell Res; 1996 Dec; 229(2):253-60. PubMed ID: 8986606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML protein expression in hematopoietic and acute promyelocytic leukemia cells.
    Daniel MT; Koken M; Romagné O; Barbey S; Bazarbachi A; Stadler M; Guillemin MC; Degos L; Chomienne C; de Thé H
    Blood; 1993 Sep; 82(6):1858-67. PubMed ID: 8400236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.